+1 347 708 0418
The NGS Based Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global NGS Based Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global NGS Based Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
NGS Based Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Market segment by Application, can be divided into
Hospitals
Clinics
Academics/Research Institutions
Market segment by players, this report covers
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe NGS Based Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of NGS Based Diagnostics, with revenue, gross margin and global market share of NGS Based Diagnostics from 2019 to 2021.
Chapter 3, the NGS Based Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and NGS Based Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe NGS Based Diagnostics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of NGS Based Diagnostics
1.2 Classification of NGS Based Diagnostics by Type
1.2.1 Overview: Global NGS Based Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global NGS Based Diagnostics Revenue Market Share by Type in 2020
1.2.3 DNA Sequencing
1.2.4 RNA Sequencing
1.2.5 Whole Genome Sequencing
1.2.6 Whole Exome Sequencing
1.2.7 Other
1.3 Global NGS Based Diagnostics Market by Application
1.3.1 Overview: Global NGS Based Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academics/Research Institutions
1.4 Global NGS Based Diagnostics Market Size & Forecast
1.5 Global NGS Based Diagnostics Market Size and Forecast by Region
1.5.1 Global NGS Based Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global NGS Based Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America NGS Based Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe NGS Based Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific NGS Based Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America NGS Based Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa NGS Based Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 NGS Based Diagnostics Market Drivers
1.6.2 NGS Based Diagnostics Market Restraints
1.6.3 NGS Based Diagnostics Trends Analysis
2 Company Profiles
2.1 Janssen
2.1.1 Janssen Details
2.1.2 Janssen Major Business
2.1.3 Janssen NGS Based Diagnostics Product and Solutions
2.1.4 Janssen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Janssen Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche NGS Based Diagnostics Product and Solutions
2.2.4 Roche NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen NGS Based Diagnostics Product and Solutions
2.3.4 Qiagen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 ThermoFisher Scientific
2.4.1 ThermoFisher Scientific Details
2.4.2 ThermoFisher Scientific Major Business
2.4.3 ThermoFisher Scientific NGS Based Diagnostics Product and Solutions
2.4.4 ThermoFisher Scientific NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ThermoFisher Scientific Recent Developments and Future Plans
2.5 Oxford Gene Technology
2.5.1 Oxford Gene Technology Details
2.5.2 Oxford Gene Technology Major Business
2.5.3 Oxford Gene Technology NGS Based Diagnostics Product and Solutions
2.5.4 Oxford Gene Technology NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Oxford Gene Technology Recent Developments and Future Plans
2.6 Illumina
2.6.1 Illumina Details
2.6.2 Illumina Major Business
2.6.3 Illumina NGS Based Diagnostics Product and Solutions
2.6.4 Illumina NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Illumina Recent Developments and Future Plans
2.7 Pacific Biosciences
2.7.1 Pacific Biosciences Details
2.7.2 Pacific Biosciences Major Business
2.7.3 Pacific Biosciences NGS Based Diagnostics Product and Solutions
2.7.4 Pacific Biosciences NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pacific Biosciences Recent Developments and Future Plans
2.8 Paradigm Diagnostics
2.8.1 Paradigm Diagnostics Details
2.8.2 Paradigm Diagnostics Major Business
2.8.3 Paradigm Diagnostics NGS Based Diagnostics Product and Solutions
2.8.4 Paradigm Diagnostics NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Paradigm Diagnostics Recent Developments and Future Plans
2.9 Innogene Kalbiotech
2.9.1 Innogene Kalbiotech Details
2.9.2 Innogene Kalbiotech Major Business
2.9.3 Innogene Kalbiotech NGS Based Diagnostics Product and Solutions
2.9.4 Innogene Kalbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Innogene Kalbiotech Recent Developments and Future Plans
2.10 Admera Health
2.10.1 Admera Health Details
2.10.2 Admera Health Major Business
2.10.3 Admera Health NGS Based Diagnostics Product and Solutions
2.10.4 Admera Health NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Admera Health Recent Developments and Future Plans
2.11 AITbiotech
2.11.1 AITbiotech Details
2.11.2 AITbiotech Major Business
2.11.3 AITbiotech NGS Based Diagnostics Product and Solutions
2.11.4 AITbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 AITbiotech Recent Developments and Future Plans
2.12 Centogene
2.12.1 Centogene Details
2.12.2 Centogene Major Business
2.12.3 Centogene NGS Based Diagnostics Product and Solutions
2.12.4 Centogene NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Centogene Recent Developments and Future Plans
2.13 Phalanx Biotech Group
2.13.1 Phalanx Biotech Group Details
2.13.2 Phalanx Biotech Group Major Business
2.13.3 Phalanx Biotech Group NGS Based Diagnostics Product and Solutions
2.13.4 Phalanx Biotech Group NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Phalanx Biotech Group Recent Developments and Future Plans
2.14 iGenomX
2.14.1 iGenomX Details
2.14.2 iGenomX Major Business
2.14.3 iGenomX NGS Based Diagnostics Product and Solutions
2.14.4 iGenomX NGS Based Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 iGenomX Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global NGS Based Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 NGS Based Diagnostics Players Market Share
3.2.2 Top 10 NGS Based Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 NGS Based Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global NGS Based Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global NGS Based Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global NGS Based Diagnostics Revenue Market Share by Application (2016-2021)
5.2 NGS Based Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America NGS Based Diagnostics Revenue by Type (2016-2026)
6.2 North America NGS Based Diagnostics Revenue by Application (2016-2026)
6.3 North America NGS Based Diagnostics Market Size by Country
6.3.1 North America NGS Based Diagnostics Revenue by Country (2016-2026)
6.3.2 United States NGS Based Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada NGS Based Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico NGS Based Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe NGS Based Diagnostics Revenue by Type (2016-2026)
7.2 Europe NGS Based Diagnostics Revenue by Application (2016-2026)
7.3 Europe NGS Based Diagnostics Market Size by Country
7.3.1 Europe NGS Based Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany NGS Based Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France NGS Based Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom NGS Based Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia NGS Based Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy NGS Based Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific NGS Based Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific NGS Based Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific NGS Based Diagnostics Market Size by Region
8.3.1 Asia-Pacific NGS Based Diagnostics Revenue by Region (2016-2026)
8.3.2 China NGS Based Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan NGS Based Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea NGS Based Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India NGS Based Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia NGS Based Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia NGS Based Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America NGS Based Diagnostics Revenue by Type (2016-2026)
9.2 South America NGS Based Diagnostics Revenue by Application (2016-2026)
9.3 South America NGS Based Diagnostics Market Size by Country
9.3.1 South America NGS Based Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil NGS Based Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina NGS Based Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa NGS Based Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa NGS Based Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa NGS Based Diagnostics Market Size by Country
10.3.1 Middle East & Africa NGS Based Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey NGS Based Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia NGS Based Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE NGS Based Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global NGS Based Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global NGS Based Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market NGS Based Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global NGS Based Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global NGS Based Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Janssen Corporate Information, Head Office, and Major Competitors
Table 7. Janssen Major Business
Table 8. Janssen NGS Based Diagnostics Product and Solutions
Table 9. Janssen NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche NGS Based Diagnostics Product and Solutions
Table 13. Roche NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Qiagen Corporate Information, Head Office, and Major Competitors
Table 15. Qiagen Major Business
Table 16. Qiagen NGS Based Diagnostics Product and Solutions
Table 17. Qiagen NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ThermoFisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. ThermoFisher Scientific Major Business
Table 20. ThermoFisher Scientific NGS Based Diagnostics Product and Solutions
Table 21. ThermoFisher Scientific NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors
Table 23. Oxford Gene Technology Major Business
Table 24. Oxford Gene Technology NGS Based Diagnostics Product and Solutions
Table 25. Oxford Gene Technology NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Illumina Corporate Information, Head Office, and Major Competitors
Table 27. Illumina Major Business
Table 28. Illumina NGS Based Diagnostics Product and Solutions
Table 29. Illumina NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pacific Biosciences Corporate Information, Head Office, and Major Competitors
Table 31. Pacific Biosciences Major Business
Table 32. Pacific Biosciences NGS Based Diagnostics Product and Solutions
Table 33. Pacific Biosciences NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Paradigm Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. Paradigm Diagnostics Major Business
Table 36. Paradigm Diagnostics NGS Based Diagnostics Product and Solutions
Table 37. Paradigm Diagnostics NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Innogene Kalbiotech Corporate Information, Head Office, and Major Competitors
Table 39. Innogene Kalbiotech Major Business
Table 40. Innogene Kalbiotech NGS Based Diagnostics Product and Solutions
Table 41. Innogene Kalbiotech NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Admera Health Corporate Information, Head Office, and Major Competitors
Table 43. Admera Health Major Business
Table 44. Admera Health NGS Based Diagnostics Product and Solutions
Table 45. Admera Health NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. AITbiotech Corporate Information, Head Office, and Major Competitors
Table 47. AITbiotech Major Business
Table 48. AITbiotech NGS Based Diagnostics Product and Solutions
Table 49. AITbiotech NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Centogene Corporate Information, Head Office, and Major Competitors
Table 51. Centogene Major Business
Table 52. Centogene NGS Based Diagnostics Product and Solutions
Table 53. Centogene NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Phalanx Biotech Group Corporate Information, Head Office, and Major Competitors
Table 55. Phalanx Biotech Group Major Business
Table 56. Phalanx Biotech Group NGS Based Diagnostics Product and Solutions
Table 57. Phalanx Biotech Group NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. iGenomX Corporate Information, Head Office, and Major Competitors
Table 59. iGenomX Major Business
Table 60. iGenomX NGS Based Diagnostics Product and Solutions
Table 61. iGenomX NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global NGS Based Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 63. Global NGS Based Diagnostics Revenue Share by Players (2019-2021)
Table 64. Breakdown of NGS Based Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. NGS Based Diagnostics Players Head Office, Products and Services Provided
Table 66. NGS Based Diagnostics Mergers & Acquisitions in the Past Five Years
Table 67. NGS Based Diagnostics New Entrants and Expansion Plans
Table 68. Global NGS Based Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 69. Global NGS Based Diagnostics Revenue Share by Type (2016-2021)
Table 70. Global NGS Based Diagnostics Revenue Forecast by Type (2021-2026)
Table 71. Global NGS Based Diagnostics Revenue by Application (2016-2021)
Table 72. Global NGS Based Diagnostics Revenue Forecast by Application (2021-2026)
Table 73. North America NGS Based Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 74. North America NGS Based Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 75. North America NGS Based Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 76. North America NGS Based Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 77. North America NGS Based Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 78. North America NGS Based Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe NGS Based Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe NGS Based Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe NGS Based Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe NGS Based Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe NGS Based Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe NGS Based Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific NGS Based Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific NGS Based Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific NGS Based Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific NGS Based Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific NGS Based Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific NGS Based Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 91. South America NGS Based Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 92. South America NGS Based Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 93. South America NGS Based Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 94. South America NGS Based Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 95. South America NGS Based Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 96. South America NGS Based Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa NGS Based Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa NGS Based Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa NGS Based Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa NGS Based Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa NGS Based Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa NGS Based Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. NGS Based Diagnostics Picture
Figure 2. Global NGS Based Diagnostics Revenue Market Share by Type in 2020
Figure 3. DNA Sequencing
Figure 4. RNA Sequencing
Figure 5. Whole Genome Sequencing
Figure 6. Whole Exome Sequencing
Figure 7. Other
Figure 8. NGS Based Diagnostics Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Academics/Research Institutions Picture
Figure 12. Global NGS Based Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global NGS Based Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global NGS Based Diagnostics Revenue Market Share by Region (2016-2026)
Figure 15. Global NGS Based Diagnostics Revenue Market Share by Region in 2020
Figure 16. North America NGS Based Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe NGS Based Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific NGS Based Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America NGS Based Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa NGS Based Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. NGS Based Diagnostics Market Drivers
Figure 22. NGS Based Diagnostics Market Restraints
Figure 23. NGS Based Diagnostics Market Trends
Figure 24. Janssen Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Qiagen Recent Developments and Future Plans
Figure 27. ThermoFisher Scientific Recent Developments and Future Plans
Figure 28. Oxford Gene Technology Recent Developments and Future Plans
Figure 29. Illumina Recent Developments and Future Plans
Figure 30. Pacific Biosciences Recent Developments and Future Plans
Figure 31. Paradigm Diagnostics Recent Developments and Future Plans
Figure 32. Innogene Kalbiotech Recent Developments and Future Plans
Figure 33. Admera Health Recent Developments and Future Plans
Figure 34. AITbiotech Recent Developments and Future Plans
Figure 35. Centogene Recent Developments and Future Plans
Figure 36. Phalanx Biotech Group Recent Developments and Future Plans
Figure 37. iGenomX Recent Developments and Future Plans
Figure 38. Global NGS Based Diagnostics Revenue Share by Players in 2020
Figure 39. NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players NGS Based Diagnostics Revenue Market Share in 2020
Figure 41. Global Top 10 Players NGS Based Diagnostics Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global NGS Based Diagnostics Revenue Share by Type in 2020
Figure 44. Global NGS Based Diagnostics Market Share Forecast by Type (2021-2026)
Figure 45. Global NGS Based Diagnostics Revenue Share by Application in 2020
Figure 46. Global NGS Based Diagnostics Market Share Forecast by Application (2021-2026)
Figure 47. North America NGS Based Diagnostics Sales Market Share by Type (2016-2026)
Figure 48. North America NGS Based Diagnostics Sales Market Share by Application (2016-2026)
Figure 49. North America NGS Based Diagnostics Revenue Market Share by Country (2016-2026)
Figure 50. United States NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe NGS Based Diagnostics Sales Market Share by Type (2016-2026)
Figure 54. Europe NGS Based Diagnostics Sales Market Share by Application (2016-2026)
Figure 55. Europe NGS Based Diagnostics Revenue Market Share by Country (2016-2026)
Figure 56. Germany NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific NGS Based Diagnostics Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific NGS Based Diagnostics Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific NGS Based Diagnostics Revenue Market Share by Region (2016-2026)
Figure 64. China NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America NGS Based Diagnostics Sales Market Share by Type (2016-2026)
Figure 71. South America NGS Based Diagnostics Sales Market Share by Application (2016-2026)
Figure 72. South America NGS Based Diagnostics Revenue Market Share by Country (2016-2026)
Figure 73. Brazil NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa NGS Based Diagnostics Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa NGS Based Diagnostics Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Country (2016-2026)
Figure 78. Turkey NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE NGS Based Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Buy
